EP 1373306 A4 20050720 - CYTOSKELETION-ASSOCIATED PROTEINS
Title (en)
CYTOSKELETION-ASSOCIATED PROTEINS
Title (de)
CYTOSKELETT ASSOZIIERTE PROTEINE
Title (fr)
PROTEINES ASSOCIEES AU CYTOSKELETON
Publication
Application
Priority
- US 0209288 W 20020325
- US 28050801 P 20010329
- US 28132301 P 20010403
- US 28376901 P 20010413
- US 28860901 P 20010504
- US 29051801 P 20010510
- US 29187001 P 20010518
- US 29445101 P 20010529
Abstract (en)
[origin: WO02079404A2] The invention provides human cytoskeleton-associated proteins (CSAP) and polynucleotides which identify and encode CSAP. The invention also providing expression vectors, host cells, antibodies, agonists, and antagonists. The invention also provides methods for diagnosing, treating, or preventing disorders associated with aberrant expression of CSAP.
IPC 1-7
IPC 8 full level
G01N 33/50 (2006.01); A61K 31/7088 (2006.01); A61K 38/00 (2006.01); A61K 39/395 (2006.01); A61K 45/00 (2006.01); A61K 48/00 (2006.01); A61P 1/16 (2006.01); A61P 7/00 (2006.01); A61P 9/10 (2006.01); A61P 17/00 (2006.01); A61P 17/06 (2006.01); A61P 19/00 (2006.01); A61P 19/04 (2006.01); A61P 21/00 (2006.01); A61P 21/04 (2006.01); A61P 25/02 (2006.01); A61P 25/08 (2006.01); A61P 25/14 (2006.01); A61P 25/16 (2006.01); A61P 25/28 (2006.01); A61P 27/02 (2006.01); A61P 31/12 (2006.01); A61P 35/00 (2006.01); A61P 43/00 (2006.01); C07K 14/47 (2006.01); C07K 16/18 (2006.01); C12M 1/00 (2006.01); C12N 1/15 (2006.01); C12N 1/19 (2006.01); C12N 1/21 (2006.01); C12N 5/10 (2006.01); C12N 15/02 (2006.01); C12N 15/09 (2006.01); C12P 21/02 (2006.01); C12P 21/08 (2006.01); C12Q 1/68 (2006.01); G01N 33/15 (2006.01); G01N 33/53 (2006.01); G01N 33/566 (2006.01); G01N 37/00 (2006.01)
CPC (source: EP)
A61P 1/16 (2017.12); A61P 7/00 (2017.12); A61P 9/10 (2017.12); A61P 17/00 (2017.12); A61P 17/06 (2017.12); A61P 19/00 (2017.12); A61P 19/04 (2017.12); A61P 21/00 (2017.12); A61P 21/04 (2017.12); A61P 25/02 (2017.12); A61P 25/08 (2017.12); A61P 25/14 (2017.12); A61P 25/16 (2017.12); A61P 25/28 (2017.12); A61P 27/02 (2017.12); A61P 31/12 (2017.12); A61P 35/00 (2017.12); A61P 43/00 (2017.12); C07K 14/47 (2013.01); A61K 38/00 (2013.01)
Citation (search report)
- [X] WO 0056883 A1 20000928 - HUMAN GENOME SCIENCES INC [US], et al
- [A] WO 0017355 A2 20000330 - INCYTE PHARMA INC [US], et al
- [E] WO 02068579 A2 20020906 - PE CORP NY [US] & DATABASE EM_PAT 3 February 2004 (2004-02-03), "Sequence 21262 from Patent WO02068579", XP002314716, retrieved from EBI Database accession no. CQ735328
- [A] SATO H ET AL: "The Genomic Organization of Type I Keratin Genes in Mice", GENOMICS, ACADEMIC PRESS, SAN DIEGO, US, vol. 56, no. 3, 15 March 1999 (1999-03-15), pages 303 - 309, XP004444979, ISSN: 0888-7543
- [A] BERNAL S D ET AL: "CYTOSKELETON-ASSOCIATED PROTEINS THEIR ROLE AS CELLULAR INTEGRATORS IN THE NEOPLASTIC PROCESS", CRITICAL REVIEWS IN ONCOLOGY-HEMATOLOGY, vol. 3, no. 3, 1985, pages 191 - 204, XP009042995, ISSN: 1040-8428
- See references of WO 02079404A2
Designated contracting state (EPC)
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR
DOCDB simple family (publication)
WO 02079404 A2 20021010; WO 02079404 A3 20030320; AU 2002306879 A1 20021015; CA 2441654 A1 20021010; EP 1373306 A2 20040102; EP 1373306 A4 20050720; JP 2004533227 A 20041104
DOCDB simple family (application)
US 0209288 W 20020325; AU 2002306879 A 20020325; CA 2441654 A 20020325; EP 02757814 A 20020325; JP 2002578407 A 20020325